Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Generics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Injectables
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Specialty Generics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Retail Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Specialty Generics Market Perspective (2018-2034)
2.2 Specialty Generics Growth Trends by Region
2.2.1 Global Specialty Generics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Specialty Generics Historic Market Size by Region (2018-2023)
2.2.3 Specialty Generics Forecasted Market Size by Region (2024-2034)
2.3 Specialty Generics Market Dynamics
2.3.1 Specialty Generics Industry Trends
2.3.2 Specialty Generics Market Drivers
2.3.3 Specialty Generics Market Challenges
2.3.4 Specialty Generics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specialty Generics Players by Revenue
3.1.1 Global Top Specialty Generics Players by Revenue (2018-2023)
3.1.2 Global Specialty Generics Revenue Market Share by Players (2018-2023)
3.2 Global Specialty Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Specialty Generics Revenue
3.4 Global Specialty Generics Market Concentration Ratio
3.4.1 Global Specialty Generics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Generics Revenue in 2024
3.5 Specialty Generics Key Players Head office and Area Served
3.6 Key Players Specialty Generics Product Solution and Service
3.7 Date of Enter into Specialty Generics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Generics Breakdown Data by Type
4.1 Global Specialty Generics Historic Market Size by Type (2018-2023)
4.2 Global Specialty Generics Forecasted Market Size by Type (2024-2034)
5 Specialty Generics Breakdown Data by Application
5.1 Global Specialty Generics Historic Market Size by Application (2018-2023)
5.2 Global Specialty Generics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Specialty Generics Market Size (2018-2034)
6.2 North America Specialty Generics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Specialty Generics Market Size by Country (2018-2023)
6.4 North America Specialty Generics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Specialty Generics Market Size (2018-2034)
7.2 Europe Specialty Generics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Specialty Generics Market Size by Country (2018-2023)
7.4 Europe Specialty Generics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Specialty Generics Market Size (2018-2034)
8.2 Asia-Pacific Specialty Generics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Specialty Generics Market Size by Region (2018-2023)
8.4 Asia-Pacific Specialty Generics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Specialty Generics Market Size (2018-2034)
9.2 Latin America Specialty Generics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Specialty Generics Market Size by Country (2018-2023)
9.4 Latin America Specialty Generics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Specialty Generics Market Size (2018-2034)
10.2 Middle East & Africa Specialty Generics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Specialty Generics Market Size by Country (2018-2023)
10.4 Middle East & Africa Specialty Generics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals Industries
11.1.1 Teva Pharmaceuticals Industries Company Detail
11.1.2 Teva Pharmaceuticals Industries Business Overview
11.1.3 Teva Pharmaceuticals Industries Specialty Generics Introduction
11.1.4 Teva Pharmaceuticals Industries Revenue in Specialty Generics Business (2018-2023)
11.1.5 Teva Pharmaceuticals Industries Recent Development
11.2 Akorn, Inc.
11.2.1 Akorn, Inc. Company Detail
11.2.2 Akorn, Inc. Business Overview
11.2.3 Akorn, Inc. Specialty Generics Introduction
11.2.4 Akorn, Inc. Revenue in Specialty Generics Business (2018-2023)
11.2.5 Akorn, Inc. Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Detail
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Specialty Generics Introduction
11.3.4 Mylan N.V. Revenue in Specialty Generics Business (2018-2023)
11.3.5 Mylan N.V. Recent Development
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Detail
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Specialty Generics Introduction
11.4.4 Mallinckrodt Revenue in Specialty Generics Business (2018-2023)
11.4.5 Mallinckrodt Recent Development
11.5 Sandoz International GmbH
11.5.1 Sandoz International GmbH Company Detail
11.5.2 Sandoz International GmbH Business Overview
11.5.3 Sandoz International GmbH Specialty Generics Introduction
11.5.4 Sandoz International GmbH Revenue in Specialty Generics Business (2018-2023)
11.5.5 Sandoz International GmbH Recent Development
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Company Detail
11.6.2 Pfizer, Inc. Business Overview
11.6.3 Pfizer, Inc. Specialty Generics Introduction
11.6.4 Pfizer, Inc. Revenue in Specialty Generics Business (2018-2023)
11.6.5 Pfizer, Inc. Recent Development
11.7 Sun Pharmaceutical Industries Ltd.
11.7.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Introduction
11.7.4 Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2018-2023)
11.7.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Detail
11.8.2 Valeant Pharmaceuticals Business Overview
11.8.3 Valeant Pharmaceuticals Specialty Generics Introduction
11.8.4 Valeant Pharmaceuticals Revenue in Specialty Generics Business (2018-2023)
11.8.5 Valeant Pharmaceuticals Recent Development
11.9 Apotex Corp.
11.9.1 Apotex Corp. Company Detail
11.9.2 Apotex Corp. Business Overview
11.9.3 Apotex Corp. Specialty Generics Introduction
11.9.4 Apotex Corp. Revenue in Specialty Generics Business (2018-2023)
11.9.5 Apotex Corp. Recent Development
11.10 Endo International plc.
11.10.1 Endo International plc. Company Detail
11.10.2 Endo International plc. Business Overview
11.10.3 Endo International plc. Specialty Generics Introduction
11.10.4 Endo International plc. Revenue in Specialty Generics Business (2018-2023)
11.10.5 Endo International plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Specialty Generics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Injectables
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Specialty Generics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Specialty Generics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Specialty Generics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Specialty Generics Market Share by Region (2018-2023)
Table 9. Global Specialty Generics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Specialty Generics Market Share by Region (2024-2034)
Table 11. Specialty Generics Market Trends
Table 12. Specialty Generics Market Drivers
Table 13. Specialty Generics Market Challenges
Table 14. Specialty Generics Market Restraints
Table 15. Global Specialty Generics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Specialty Generics Market Share by Players (2018-2023)
Table 17. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2024)
Table 18. Ranking of Global Top Specialty Generics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Specialty Generics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Specialty Generics Product Solution and Service
Table 22. Date of Enter into Specialty Generics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Specialty Generics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Specialty Generics Revenue Market Share by Type (2018-2023)
Table 26. Global Specialty Generics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Specialty Generics Revenue Market Share by Type (2024-2034)
Table 28. Global Specialty Generics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Specialty Generics Revenue Market Share by Application (2018-2023)
Table 30. Global Specialty Generics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Specialty Generics Revenue Market Share by Application (2024-2034)
Table 32. North America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Specialty Generics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Specialty Generics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Specialty Generics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Specialty Generics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Specialty Generics Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Specialty Generics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Specialty Generics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 47. Teva Pharmaceuticals Industries Company Detail
Table 48. Teva Pharmaceuticals Industries Business Overview
Table 49. Teva Pharmaceuticals Industries Specialty Generics Product
Table 50. Teva Pharmaceuticals Industries Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 51. Teva Pharmaceuticals Industries Recent Development
Table 52. Akorn, Inc. Company Detail
Table 53. Akorn, Inc. Business Overview
Table 54. Akorn, Inc. Specialty Generics Product
Table 55. Akorn, Inc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 56. Akorn, Inc. Recent Development
Table 57. Mylan N.V. Company Detail
Table 58. Mylan N.V. Business Overview
Table 59. Mylan N.V. Specialty Generics Product
Table 60. Mylan N.V. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 61. Mylan N.V. Recent Development
Table 62. Mallinckrodt Company Detail
Table 63. Mallinckrodt Business Overview
Table 64. Mallinckrodt Specialty Generics Product
Table 65. Mallinckrodt Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 66. Mallinckrodt Recent Development
Table 67. Sandoz International GmbH Company Detail
Table 68. Sandoz International GmbH Business Overview
Table 69. Sandoz International GmbH Specialty Generics Product
Table 70. Sandoz International GmbH Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 71. Sandoz International GmbH Recent Development
Table 72. Pfizer, Inc. Company Detail
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Specialty Generics Product
Table 75. Pfizer, Inc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 76. Pfizer, Inc. Recent Development
Table 77. Sun Pharmaceutical Industries Ltd. Company Detail
Table 78. Sun Pharmaceutical Industries Ltd. Business Overview
Table 79. Sun Pharmaceutical Industries Ltd. Specialty Generics Product
Table 80. Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 81. Sun Pharmaceutical Industries Ltd. Recent Development
Table 82. Valeant Pharmaceuticals Company Detail
Table 83. Valeant Pharmaceuticals Business Overview
Table 84. Valeant Pharmaceuticals Specialty Generics Product
Table 85. Valeant Pharmaceuticals Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 86. Valeant Pharmaceuticals Recent Development
Table 87. Apotex Corp. Company Detail
Table 88. Apotex Corp. Business Overview
Table 89. Apotex Corp. Specialty Generics Product
Table 90. Apotex Corp. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 91. Apotex Corp. Recent Development
Table 92. Endo International plc. Company Detail
Table 93. Endo International plc. Business Overview
Table 94. Endo International plc. Specialty Generics Product
Table 95. Endo International plc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)
Table 96. Endo International plc. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Generics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Specialty Generics Market Share by Type: 2024 VS 2034
Figure 3. Injectables Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Specialty Generics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Specialty Generics Market Share by Application: 2024 VS 2034
Figure 8. Retail Pharmacies Case Studies
Figure 9. Specialty Pharmacies Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Specialty Generics Report Years Considered
Figure 12. Global Specialty Generics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Specialty Generics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Specialty Generics Market Share by Region: 2024 VS 2034
Figure 15. Global Specialty Generics Market Share by Players in 2024
Figure 16. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Specialty Generics Revenue in 2024
Figure 18. North America Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Specialty Generics Market Share by Country (2018-2034)
Figure 20. United States Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Specialty Generics Market Share by Country (2018-2034)
Figure 24. Germany Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Specialty Generics Market Share by Region (2018-2034)
Figure 32. China Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Specialty Generics Market Share by Country (2018-2034)
Figure 40. Mexico Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Specialty Generics Market Share by Country (2018-2034)
Figure 44. Turkey Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Specialty Generics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Teva Pharmaceuticals Industries Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 47. Akorn, Inc. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 48. Mylan N.V. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 49. Mallinckrodt Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 50. Sandoz International GmbH Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 51. Pfizer, Inc. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 52. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 53. Valeant Pharmaceuticals Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 54. Apotex Corp. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 55. Endo International plc. Revenue Growth Rate in Specialty Generics Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed